A study today in the New England Journal of Medicine reports that childhood mortality in sub-Saharan African communities randomly assigned to mass distribution of azithromycin was lower than in those assigned a placebo. But the authors warn that resistance emerging from mass distribution of the antibiotic could curb or reverse any potential benefit.
A study yesterday in the American Journal of Infection Control has found that only 62% of reported cases of healthcare facility–onset Clostridium difficile (HO-CDI) at a New York hospital met clinical criteria.
A study group with the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) reports that 45% of specialists in infectious diseases and clinical microbiology sometimes worried and 29% often worried about malpractice implications when prescribing or advising on antibiotic prescriptions, and 85% reported defensive behaviors when prescribing, according to a study today in the Journal of Antimicrobial Ch
From 2013 through 2017 European officials recorded 620 cases of Candida auris, mostly from four large outbreaks, and 110 of them (17.7%) involved bloodstream infections, according to a report today in Eurosurveillance.
A survey of 244 members of three infectious diseases societies reveals that the most common approached to antimicrobial stewardship programs (ASPs) are antibiotic reviews with prospective audit and feedback (PAF), prior authorization for select antibiotics, and guideline development, according to a study today in Clinical Infectious Diseases.
A new surveillance report from the European Centre for Disease Prevention and Control (ECDC) shows that the tuberculosis (TB) incidence rate in Europe is declining by an average of 4.3% a year, the fastest decline in the world compared with other regions. But officials warn that it's not falling fast enough to achieve the World Health Organization (WHO) goal of TB elimination in Europe by 2050.
Researchers in Italy report widespread diffusion of multidrug-resistant (MDR) bacteria in residents from long-term care facilities (LTCFs) in three different northern Italian regions, according to a study yesterday in Antimicrobial Resistance and Infection Control.
A survey of medical residents found that 28% to 51% could not accurately identify pathogens to target with empiric therapy or select therapy with an appropriate spectrum of activity, and only 12% of respondents identified antibiograms as a prescribing resource, according to a study yesterday in Infection Control & Hospital Epidemiology.
A systematic review of treatments for Clostridium difficile infection (CDI) yesterday in Infection Control and Hospital Epidemiology concludes that the most cost-effective treatment remains unclear.
IDSA/SHEA guidelines recommend fecal microbiota transplantation for patients with multiple recurrences.
